About $3,000 carries one veteran through this phase — every gift is measured in lives, not just dollars.
- Participants
- 50 (40 funded, 10 in-kind)
- Design
- Single-arm, open-label
- Intervention
- Advanced Orthogonal (C1000)
- Imaging
- In-clinic X-ray (pre/post)
- Duration
- 6 months
- Total ask
- $384,702
Phase 1 asks the first and most fundamental question, and answers it. In fifty veterans living with persistent symptoms, it tests whether correcting alignment at the craniocervical junction produces measurable improvement, using nothing but precise, image-guided upper cervical care. These are people who have often already tried everything the conventional system offers. Phase 1 gives them a genuinely different approach, and it measures the result with real instruments: validated symptom scales, neurological and cognitive testing, balance and sensory-motor evaluation, and imaging before and after.
The impact of this phase reaches well beyond the fifty who take part. Its findings become the first published evidence that the craniocervical model works — evidence shared openly with the biomedical and military research communities. In the language of federal science, this is the preliminary data that opens doors. Without it, the larger trial is a hypothesis. With it, the larger trial becomes a credible, fundable national priority.
What it proves
Recruitment and retention feasibility, protocol fidelity, and a within-subject signal on symptomatic, neurocognitive, and neurological measures — producing the peer-reviewed preliminary dataset that federal funding mechanisms require as pilot data.
Your support here coversThe care these veterans receive, the clinical and neurological evaluations that document their progress, the foundational data system that carries every future phase, the ethical and regulatory oversight that protects participants, the financial stewardship that keeps the work accountable, and the publication that shares what is learned.
Last updated August 15, 2026